Study holds promise for new pediatric brain tumor treatment
(Huntsman Cancer Institute) New research published in Nature Communications from scientists at Huntsman Cancer Institute (HCI) at the University of Utah (U of U), in collaboration with the Stanford University School of Medicine, shows a specific protein regulates both the initiation of cancer spreading and the self-renewal of cancer cells in medulloblastoma, a type of pediatric brain cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 11, 2018 Category: Cancer & Oncology Source Type: news

High-resolution genomic map gives scientists unprecedented view of brain development
(St. Jude Children's Research Hospital) The research will not only aid basic understanding of brain development, but also provide a foundation for understanding the cellular origins of brain disorders caused by errors in development. These anatomical defects include Joubert syndrome, Dandy-Walker malformation and pontocerebellar hypoplasia. The database will enable future studies tracing the cellular origins of childhood brain tumors such as medulloblastoma, astrocytoma and ependymoma.Researchers worldwide can interact with the data via an interface St. Jude has created called Cell Seek. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 13, 2018 Category: Biology Source Type: news

A target for medulloblastoma
(Source: ScienceNOW)
Source: ScienceNOW - September 13, 2018 Category: Science Authors: Ferrarelli, L. K. Tags: twis Source Type: news

Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma
A major limitation of targeted cancer therapy is the rapid emergence of drug resistance, which often arises through mutations at or downstream of the drug target or through intrinsic resistance of subpopulations of tumor cells. Medulloblastoma (MB), the most common pediatric brain tumor, is no exception, and MBs that are driven by sonic hedgehog (SHH) signaling are particularly aggressive and drug-resistant. To find new drug targets and therapeutics for MB that may be less susceptible to common resistance mechanisms, we used a developmental phosphoproteomics approach in murine granule neuron precursors (GNPs), the developm...
Source: Signal Transduction Knowledge Environment - September 11, 2018 Category: Science Authors: Purzner, T., Purzner, J., Buckstaff, T., Cozza, G., Gholamin, S., Rusert, J. M., Hartl, T. A., Sanders, J., Conley, N., Ge, X., Langan, M., Ramaswamy, V., Ellis, L., Litzenburger, U., Bolin, S., Theruvath, J., Nitta, R., Qi, L., Li, X.-N., Li, G., Taylor, Tags: STKE Research Articles Source Type: news

Stem cells show promise as drug delivery tool for childhood brain cancer
(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger Comprehensive Cancer Center researchers showed they could shrink tumors in laboratory models of medulloblastoma, and extend life. The study, published in PLOS ONE, is a necessary step toward developing clinical trials that would see if the approach works for children. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 29, 2018 Category: International Medicine & Public Health Source Type: news

Childhood Brain Tumor Radiation Can Hinder Memory
Radiation treatment for medulloblastoma, the most common type of childhood brain tumor, can leave young survivors struggling to remember recent events, a small study has found. But survivors' ability to recall things that happened before radiation wasn't affected. (Source: WebMD Health)
Source: WebMD Health - August 21, 2018 Category: Consumer Health News Source Type: news

SNMMI: Molecular imaging method monitors gene therapy
PHILADELPHIA - A new molecular imaging method can monitor the level and location...Read more on AuntMinnie.comRelated Reading: SNMMI: AI can avoid patient misidentification on PET/CT SNMMI: New therapy aids patients with neuroendocrine tumors SNMMI 2018: A year of promotion and ongoing challenges Machine learning may identify medulloblastoma subtypes DWI-MRI could help show gene expression in tumors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 26, 2018 Category: Radiology Source Type: news

Reviving the protector: new tactic against medulloblastoma
(Emory Health Sciences) Scientists have a new tactic with potential for fighting medulloblastoma, the most common and most aggressive form of brain tumor in children. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2018 Category: Cancer & Oncology Source Type: news

St. Jude trial identifies a medulloblastoma subset that requires less aggressive therapy
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital researchers have identified a subtype of the brain tumor medulloblastoma that is associated with improved survival of infants treated with less aggressive, risk-adapted therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

Genetic analysis for certain childhood brain tumors soon a standard-of-care?
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) An international team of researchers from the Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), the European Molecular Biology Laboratory (EMBL) and the German Cancer Consortium (DKTK) together with colleagues at the St. Jude Children's Research Hospital in Memphis and the Hospital for Sick Children in Toronto has summarized hereditary gene defects which can trigger the development of certain malignant brain tumors (medulloblastoma). From their findings, the team has derived recommendations for routine genetic screening in medulloblastoma pa...
Source: EurekAlert! - Cancer - May 11, 2018 Category: Cancer & Oncology Source Type: news

Genetic counseling and testing proposed for patients with the brain tumor medulloblastoma
(St. Jude Children's Research Hospital) Researchers have created the first genetic screening guidelines for medulloblastoma patients after identifying gene variations that make carriers susceptible to develop the brain tumor and possibly other cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2018 Category: International Medicine & Public Health Source Type: news

PD-L1 expression in medulloblastoma: An evaluation by subgroup
This study evaluated the expression of PD-L1 and markers of immune mediated resistance in human medulloblastoma, the most common malignant pediatric brain tumor. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 2, 2018 Category: Cancer & Oncology Source Type: news

Funding the search for a cancer cure
Rider and Victoria McDowell made a fortune together, and produced real riches with the birth of three boys. But five years ago their son Errol was diagnosed with medulloblastoma, a rare brain cancer. After an experimental drug slowed the disease, they are now helping fund research in pediatric brain cancer in the hope of finding a cure. Tracy Smith reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 15, 2018 Category: Consumer Health News Source Type: news

Deep learning performs superresolution MSK MRI
A deep-learning algorithm can transform low-resolution, thick-slice knee MR...Read more on AuntMinnie.comRelated Reading: Machine learning may identify medulloblastoma subtypes Is artificial intelligence ethical in healthcare? Deep learning may produce sharp reductions in DBT dose AI can help distinguish lung nodules on CT scans Can AI help in the fight against gadolinium deposition? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 11, 2018 Category: Radiology Source Type: news

Machine learning may identify medulloblastoma subtypes
The combination of machine learning and radiomics can predict the molecular...Read more on AuntMinnie.comRelated Reading: Is artificial intelligence ethical in healthcare? Deep learning may produce sharp reductions in DBT dose Deep learning can detect intracranial calcifications on CT Deep learning can quantify CAC on low-dose CT Deep-learning algorithm can stratify lung nodule risk (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 22, 2018 Category: Radiology Source Type: news

In the eye of the medulloblastoma
(CNRS) Can genes normally expressed only in the eye be activated in brain tumors? Such a phenomenon, though surprising, has been observed in certain types of medulloblastoma, pediatric tumors of the cerebellum. Researchers from the CNRS, Institut Curie, Inserm and Universit é Paris-Sud, together with colleagues at St. Jude Children's Research Hospital, have pinpointed the role of these genes in the tumor process, thus offering new therapeutic targets. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 12, 2018 Category: Cancer & Oncology Source Type: news

Atoh1, a potential Achilles' heel of Sonic Hedgehog medulloblastoma
(Baylor College of Medicine) Tyrosine 78 in Atoh1 is phosphorylated exclusively in 'tumor-initiating cells' in sonic hedgehog medulloblastoma and reducing the levels of Atoh1 promotes tumor regression in mice and provides a potential future strategy for treating this type of tumor. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 12, 2017 Category: Cancer & Oncology Source Type: news

New weakness found in most common childhood malignant brain tumor
(Queen Mary University of London) A new weakness found in medulloblastoma, the most common form of childhood brain tumor, could lead to more personalized medicine and improved treatment for some patients, according to an early study by Queen Mary University of London. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2017 Category: Cancer & Oncology Source Type: news

Promising target for treating brain tumors in children
(Ann& Robert H. Lurie Children's Hospital of Chicago) Findings published in Oncotarget offer new hope for children with highly aggressive brain tumors like atypical teratoid/rhabdoid tumor (AT/RT) and medulloblastoma. Previously, the authors of the study have shown that an experimental drug that inhibits polo-like kinase 4 (PLK4) stopped pediatric brain tumor growth in vitro. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 27, 2017 Category: International Medicine & Public Health Source Type: news

Florida boy diagnosed with brain tumor after concussion
Logan Silva, seven, was diagnosed with medulloblastoma, a fast-growing brain tumor. After getting a concussion, the boy from Florida suffered extreme headaches which turned out to be a tumor. (Source: the Mail online | Health)
Source: the Mail online | Health - November 2, 2017 Category: Consumer Health News Source Type: news

New study discovers faulty genes underlying brain tumours
A new in-depth study funded by Cancer Research UK has shown that medulloblastoma brain tumours have faulty genes underlying the disease. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 26, 2017 Category: Pharmaceuticals Source Type: news

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors
(St. Jude Children's Research Hospital) An international consortium co-led by St. Jude Children's Research Hospital completed a landmark study of most common pediatric brain tumor, revealing new cancer genes, laying the foundation to expand precision medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 19, 2017 Category: Cancer & Oncology Source Type: news

Researchers identify a key controller of biological machinery in cell's 'antenna'
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital discovery of a regulatory enzyme working at the primary cilium could lead to treatments for the brain tumor medulloblastoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 6, 2017 Category: Cancer & Oncology Source Type: news

PID1 gene enhances effectiveness of chemotherapy on brain cancer cells
The gene PID1 enhances killing of medulloblastoma and glioblastoma cells, investigators have found. Medulloblastoma is the most commonly occurring malignant primary brain tumor in children; glioblastoma is the most commonly occurring malignant primary brain tumor in adults. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 11, 2017 Category: Science Source Type: news

PID1 gene enhances effectiveness of chemotherapy on brain cancer cells
(Children's Hospital Los Angeles) Investigators at The Saban Research Institute of Children's Hospital Los Angeles have found that the gene PID1 enhances killing of medulloblastoma and glioblastoma cells. Medulloblastoma is the most commonly occurring malignant primary brain tumor in children; glioblastoma is the most commonly occurring malignant primary brain tumor in adults. Results of this study will be published in Scientific Reports on April 11. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 11, 2017 Category: Global & Universal Source Type: news

Caution needed for drugs in development for most common malignant pediatric brain tumor
(St. Jude Children's Research Hospital) Researchers at St. Jude Children's Research Hospital have studied how a crucial cancer-related protein plays a role in one of the most aggressive forms of medulloblastoma, the most common malignant brain tumor of childhood. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 21, 2017 Category: Cancer & Oncology Source Type: news

Molecular'on switch' could point to treatments for pediatric brain tumor
Massachusetts General Hospital researchers have identified a mechanism that controls the expression of genes regulating the growth of the most aggressive form of medulloblastoma, the most common pediatric brain tumor. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 24, 2017 Category: Science Source Type: news

Molecular 'on switch' could point to treatments for pediatric brain tumor
(Massachusetts General Hospital) Massachusetts General Hospital researchers have identified a mechanism that controls the expression of genes regulating the growth of the most aggressive form of medulloblastoma, the most common pediatric brain tumor. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 24, 2017 Category: Cancer & Oncology Source Type: news

Husband-wife team at Children ’s Mercy declares war on brain cancer
Children ’s Mercy Chief Scientific Officer Tom Curran and Assistant Professor of Pediatrics Jessie Ng have a long history. The husband-and-wife duo have worked together for more than a decade, evaluating pediatric brain cancer treatments. Before Curran joined Children’s Mercy in February 2016, Ng worked for Curran at the Children’s Hospital of Philadelphia, where he led translational childhood cancer research. Among numerous projects, he and Ng tested a new treatment for medulloblastoma, the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 17, 2017 Category: American Health Authors: Elise Reuter Source Type: news

ASTRO releases updated APBI guide
The American Society for Radiation Oncology (ASTRO) has released an updated...Read more on AuntMinnie.comRelated Reading: ASTRO: PET predicts outcomes in vulvar cancer patients ASTRO: Radiation boost cuts local recurrence in DCIS patients ASTRO: Negative PET/CT doesn't always mean dormant NSCLC ASTRO: Prostate cancer has 3 molecular subtypes ASTRO: OK to cut RT dose for primary medulloblastoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 17, 2016 Category: Radiology Source Type: news

Genetic signaling pathway blocks formation of a cancer in the cerebellum
A signaling pathway has the potential to block a type of cancer in the cerebellum, suggests new research. The work is focused on brain tumor formation in animal models of medulloblastoma, the most common malignant brain tumor diagnosed in children. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 8, 2016 Category: Science Source Type: news

Adding Chemotherapy in Medulloblastoma Linked With Improved Survival
A recent retrospective study found that adding chemotherapy to postoperative treatment of craniospinal radiation for adults with medulloblastoma improves survival. (Source: CancerNetwork)
Source: CancerNetwork - November 4, 2016 Category: Cancer & Oncology Authors: Benjamin Kann, MD Tags: Brain Tumors Radiation Oncology Source Type: news

Could targeting a gene linked to microcephaly lead to a better brain cancer treatment?
(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger Comprehensive Cancer Center researchers report preclinical findings showing promise for targeting a gene linked to microcephaly in infants as a treatment for medulloblastoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 1, 2016 Category: Cancer & Oncology Source Type: news

Shortened RT works for low-risk prostate cancer patients
A shortened, higher-dose radiation therapy (RT) protocol is safe for low-risk...Read more on AuntMinnie.comRelated Reading: ASTRO: PET predicts outcomes in vulvar cancer patients ASTRO: Radiation boost cuts local recurrence in DCIS patients ASTRO: Negative PET/CT doesn't always mean dormant NSCLC ASTRO: Prostate cancer has 3 molecular subtypes ASTRO: OK to cut RT dose for primary medulloblastoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 4, 2016 Category: Radiology Source Type: news

Markers Could Improve Treatment Stratification for Pediatric Medulloblastoma
The use of an intensified treatment regimen to treat metastatic medulloblastoma in children and adolescents conferred an overall favorable survival, according to the results of a recent study. However, patients within varying subgroups and with certain biologic parameters did not have uniform outcomes. (Source: CancerNetwork)
Source: CancerNetwork - October 3, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Brain Tumors Pediatric Cancers Source Type: news

ASTRO: OK to cut RT dose for primary medulloblastoma
Reduced doses for radiation therapy (RT) for pediatric medulloblastoma at the...Read more on AuntMinnie.comRelated Reading: Pediatric proton therapy treatments on the rise SNMMI: PET, MRI may predict pediatric brain tumor outcomes ASTRO: Study lauds proton therapy Imaging advances therapy assessment Proton therapy offers hope to pediatric brain cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 26, 2016 Category: Radiology Source Type: news

Medulloblastoma patients should receive both chemotherapy and radiation post-surgery
The addition of chemotherapy to postoperative treatment for adults with medulloblastoma improves survival, new research demonstrates. Medulloblastoma (MB) is the most common brain tumor in children, but is relatively rare in adults. Chemotherapy use in adult MB is largely based on pediatric outcomes, and its effectiveness has been unclear. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 26, 2016 Category: Science Source Type: news

DelMar, Accurexa ink deal for chemotherapy combo
DelMar Pharmaceuticals and Accurexa  said today that they inked a deal to collaborate on a combination chemotherapy for local treatment of brain cancer. The agreement calls for DelMar to supply the drug dianhydrogalactitol (VAL-083) as part of a combination with another chemotherapeutic, either temozolomide or carmustine, for local delivery to the tumor via Accurexa’s ACX-31 implantable polymer wafer. DelMar said its drug proved successful in more than 40 clinical trials sponsored by the U.S. National Cancer Institute, winning orphan drug designation as a treatment for gliomas, medulloblastoma and ovarian c...
Source: Mass Device - September 7, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Neurological Oncology Pharmaceuticals Research & Development Accurexa Inc. DelMar Pharmaceuticals Source Type: news

Deferring Postoperative RT for Pediatric Medulloblastoma Affected Survival
The deferral of postoperative radiotherapy is increasing among children with medulloblastoma, and this deferral of treatment was associated with worse survival. (Source: CancerNetwork)
Source: CancerNetwork - August 26, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Brain Tumors News Source Type: news

Brain Function Differs By Medulloblastoma Subtype
Patients with different molecular subtypes of medulloblastoma, a common type of childhood brain tumor, have varying decline in brain function following radiation therapy for their disease. (Source: CancerNetwork)
Source: CancerNetwork - August 10, 2016 Category: Cancer & Oncology Authors: Anna Azvolinsky Tags: Brain Tumors News Pediatric Cancers Source Type: news

[Report] Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
Cancers often evade immune surveillance by adopting peripheral tissue– tolerance mechanisms, such as the expression of programmed cell death ligand 1 (PD-L1), the inhibition of which results in potent antitumor immunity. Here, we show that cyclin-dependent kinase 5 (Cdk5), a serine-threonine kinase that is highly active in postmitotic neurons and in many cancers, allows medulloblastoma (MB) to evade immune elimination. Interferon-γ (IFN-γ)–induced PD-L1 up-regulation on MB requires Cdk5, and disruption of Cdk5 expression in a mouse model of MB results in potent CD4+ T cell–mediated tumor rejec...
Source: ScienceNOW - July 21, 2016 Category: Science Authors: R. Dixon Dorand Source Type: news

In The Loop: Biology Professor Has Helping Others Down to a Science
This story originally appeared on the In the Loop blog. ____________________ In the summer of 2013, Anika Geibel was diagnosed with medulloblastoma, a type of brain tumor. She was just 7 1/2 years old. The diagnosis turned her life — and the lives of her family members — upside down. "We had been medically evacuated from Africa (where [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 4, 2016 Category: Databases & Libraries Source Type: news

Scientists uncover novel therapeutic targets and candidate biomarkers in childhood cancers
(Write Science Right) Brazilian scientists have obtained evidence suggesting that neurotrophins, which are well-known signaling molecules in normal brain development and function, may be useful biomarkers and therapeutic targets in childhood cancers. Blockade of the receptors that mediate neurotrophin signaling, namely TrkA and TrkB, have been shown to produce anticancer effects in both Ewing sarcoma and medulloblastoma. Additionally, levels of a neurotrophin have been associated with leukemia prognosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 18, 2016 Category: Cancer & Oncology Source Type: news

Oncurious begins Phase I/IIa study of TB-403 to treat medulloblastoma
Oncurious, along with BioInvent International and Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC), has begun a Phase I/IIa study to evaluate the safety, tolerability and preliminary efficacy of TB-403 for the treatment of … (Source: Drug Development Technology)
Source: Drug Development Technology - May 2, 2016 Category: Pharmaceuticals Source Type: news

Adaptive Therapy May Help Kids Cope With Cancer
BOSTON (CBS) — Salma Costa, now five years old, had surgery, nine months of chemotherapy and then radiation which knocked her off her feet. The young girl suffers from medulloblastoma, an aggressive form of brain cancer. Fabiana Costa, Salma’s mom says, “She was very nauseaou. She would be vomiting all day. She didn’t want to play or do anything. She just wanted to lay down.” Despite aggressive treatment for , her tumor came back and doctors referred her to palliative care. But her mom was afraid to give up. “I called her doctor and I begged her to help us out with any trial treatments...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 18, 2016 Category: Consumer Health News Authors: mouellette2015 Tags: Health Healthwatch Local News Seen On WBZ-TV Syndicated Local Watch Listen Cancer Dr. Mallika Marshall Source Type: news

BioInvent, Oncurious and US research consortium collaborate on TB-403 Phase I/IIa cancer trial
BioInvent International (BINV) and Oncurious have collaborated with the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) to accelerate a Phase I/IIa trial of TB-403. (Source: Drug Development Technology)
Source: Drug Development Technology - March 16, 2016 Category: Pharmaceuticals Source Type: news

New drug combination shows promise against childhood brain cancer
(Sanford-Burnham Prebys Medical Discovery Institute) Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new combination therapy for the most aggressive form of medulloblastoma, a fast growing pediatric brain cancer. In a study published online today in Cancer Cell, they show that panobinostat, an HDAC inhibitor, combined with a PI3K inhibitor, significantly slows growth of MYC-driven medulloblastomas. These results are expected to lead to a clinical trial to confirm the benefits of the novel drug combination. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 14, 2016 Category: Cancer & Oncology Source Type: news

Hertfordshire woman told she could be pregnant learns she has BRAIN CANCER
Christine Tang, now 26, of Hemel Hempstead, Hertfordshire, was diagnosed with stage 4 medulloblastoma, a form of brain tumour rarely seen in adults. (Source: the Mail online | Health)
Source: the Mail online | Health - February 16, 2016 Category: Consumer Health News Source Type: news

Favourable safety, disease control for proton radiotherapy in paediatric medulloblastoma
Proton radiotherapy has an acceptable safety and disease control profile in paediatric medulloblastoma patients, according to research published in The Lancet Oncology. (Source: MedWire News)
Source: MedWire News - February 11, 2016 Category: Consumer Health News Tags: Neuro-oncology Source Type: news

Proton Beam in Medulloblastoma: 'New Benchmark'Proton Beam in Medulloblastoma: 'New Benchmark'
In children with medulloblastoma, proton-beam therapy has survival rates similar to standard radiotherapy, but fewer systemic toxicities. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 4, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news